Affordable Access

deepdyve-link
Publisher Website

A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.

Authors
  • Ke, J
  • Wu, X
  • Wu, X
  • He, X
  • Lian, L
  • Zou, Y
  • He, X
  • Wang, H
  • Luo, Y
  • Wang, L
  • Lan, P
Type
Published Article
Journal
Neoplasma
Publication Date
Jan 01, 2012
Volume
59
Issue
3
Pages
282–288
Identifiers
DOI: 10.4149/neo_2012_036
PMID: 22329848
Source
Medline
License
Unknown

Abstract

Cancer stem cells (CSCs) have been shown to contribute to the resistance and relapse in a range of cancer types such as breast cancer and glioma. However, colon cancer stem cells remain poorly characterized. Here we reported that CD24+ subpopulation in colon cancer cell lines HCT116 and SW480 exhibited cancer stem cell-like characteristics. Using flow cytometry candidate CSCs markers were selected after initial screening of known CSCs markers from other types of cancer on colon cancer cell lines HCT116, SW480 and HT29. CD24 was expressed in the minority of bulk cell population of HCT116 and SW480 cell lines. Moreover, functional tests demonstrated that CD24+ cells exhibited enhanced chemotherapy-resistance, self-renewal and tumorigenic capacity both in vitro and in vivo, compared to CD24- subpopulations. These results suggest that CD24+ subpopulation in colon cancer cell lines HCT116 and SW480 exhibits CSCs like characteristics, and represents a nice model to study and develop effective strategies to overcome chemo-resistance and relapse of colon cancer.

Report this publication

Statistics

Seen <100 times